EAPH (Easton Pharmaceuticals) ROE % Adjusted to Book Value: -251.00% (As of Sep. 2021)


EAPH Easton Pharmaceuticals Inc EAPH
12 GF Score
Price $0.00
View Full Analysis

What is Easton Pharmaceuticals ROE % Adjusted to Book Value?

Easton Pharmaceuticals EAPH -95.00% 12 ROE % Adjusted to Book Value is -251.00% as of Sep. 2021. GuruFocus rates EAPH with a GF Score™ of 12/100.

Easton Pharmaceuticals's ROE % for the quarter that ended in Sep. 2021 was -5.02%. Easton Pharmaceuticals's PB Ratio for the quarter that ended in Sep. 2021 was 0.02. Easton Pharmaceuticals's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2021 was -251.00%.

Easton Pharmaceuticals ROE % Adjusted to Book Value Related Terms

Easton Pharmaceuticals ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Easton Pharmaceuticals's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Easton Pharmaceuticals ROE % Adjusted to Book Value Chart

Easton Pharmaceuticals Annual Data
Trend Dec01 Dec02 Dec03 Dec04 Dec18 Dec19 Dec20
ROE % Adjusted to Book Value
Get a 7-Day Free Trial 0.00 -446.22 -2.70 -22.70 -22.50

Easton Pharmaceuticals Quarterly Data
Jun02 Sep02 Dec02 Mar03 Jun03 Sep03 Dec03 Mar04 Jun04 Sep04 Dec04 Mar05 Jun05 Sep05 Dec18 Dec19 Dec20 Mar21 Jun21 Sep21
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 -12.30 -78.83 -251.00

EAPH vs FPSUF, GCAN, ACUR: ROE % Adjusted to Book Value Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Easton Pharmaceuticals's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Easton Pharmaceuticals ROE % Adjusted to Book Value vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Easton Pharmaceuticals's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Easton Pharmaceuticals's ROE % Adjusted to Book Value falls into.


EAPH
12GF Score
Easton Pharmaceuticals Inc EAPH
ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Easton Pharmaceuticals ROE % Adjusted to Book Value Calculation

Easton Pharmaceuticals's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2020 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-2.70% / 0.12
=-22.50%

Easton Pharmaceuticals's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2021 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-5.02% / 0.02
=-251.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of -251.00% mean?
Easton Pharmaceuticals (EAPH) has a ROE % Adjusted to Book Value of -251.00% as of Sep. 2021. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Easton Pharmaceuticals and its competitors.
Is Easton Pharmaceuticals' ROE % Adjusted to Book Value too high?
Easton Pharmaceuticals' current ROE % Adjusted to Book Value is -251.00%. Overall, Easton Pharmaceuticals has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Easton Pharmaceuticals' ROE % Adjusted to Book Value compare to FPSUF and GCAN?
Easton Pharmaceuticals' ROE % Adjusted to Book Value of -251.00% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Drug Manufacturers company?
A good ROE % Adjusted to Book Value depends on the Drug Manufacturers industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Easton Pharmaceuticals and its competitors. Easton Pharmaceuticals's current ROE % Adjusted to Book Value is -251.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Easton Pharmaceuticals stock overvalued right now?
Easton Pharmaceuticals (EAPH) has a current ROE % Adjusted to Book Value of -251.00%. The current ROE % Adjusted to Book Value is -251.00%. Easton Pharmaceuticals' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Easton Pharmaceuticals (EAPH), the current ROE % Adjusted to Book Value is -251.00% as of Sep. 2021. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Easton Pharmaceuticals Business Description

Address 2 Bloor Street East, Suite 3500, Toronto, ON, CAN, M4W 1A8
Easton Pharmaceuticals Inc is a diversified specialty pharmaceutical company. It owns and develops proprietary transdermal delivery technology and therapeutic over the counter products and drugs to treat cancer and other diseases. The company also owns exclusive distribution rights in Mexico and Latin America for patented women's diagnostic and preventative care products. It is focused on the development of product Viorra. The firm's products include Nauseasol, Skin Renou HA, Kenestrin gel, and XILIVE, among others.
12GF Score

Get the complete analysis for EAPH

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price